Essayer OR - Gratuit
Can Covid-19 Pandemic Fast Track Digital Transformation?
BioSpectrum Asia
|April 2020
COVID-19 will have a far-reaching effect on business communities globally. This crisis is seen as an inflection point in the drive toward digitization across businesses globally. The connected, digital economy is helping enterprises, employees, and consumers remain engaged and do business, even as the virus continues to spread. This crisis has made it clear in the business world, more so than ever, that investing in emerging digital technologies can potentially do a world of good. The growing dependency on business conferencing tools, e-commerce, digital learning, VR-based training, and business apps supporting remote workers cannot be dismissed as a blip and is likely to remain the new norm among businesses worldwide. BioSpectrum illuminates few technologies joining the world’s battle to combat coronavirus.
The impacts and consequences of Coronavirus pandemic on societies are immense to be tackled with existing healthcare systems in order to secure lives, healthcare, businesses and stabilise economies. Though the pandemic is blowing away industries and market, digital technology is emerging to assist in COVID-19 pandemic warfare.
Emerging digital technologies have potentials to drastically influence accessibility, tracing, diagnosis and treatment to track COVID-19 global impairment. Companies are transforming their business models to fast-track the innovations and discoveries at medical and diagnostic care. Technology powered by artificial intelligence (AI) is also encouraging and expediting innovations. Advanced cloud-based technology applications Alibaba Cloud, the data intelligence backbone of Alibaba Group is offering “advanced cloud-based technology applications” for medical personnel around the world to fight against the COVID-19 pandemic.
Alibaba Cloud’s solution experts, scientists and researchers from Alibaba DAMO Academy and the technical team at DingTalk have joined together to develop a series of cloud-native anti-coronavirus solutions.
DingTalk’s International Medical Expert Communication Platform, hosted on Alibaba Cloud provides a means of free communication for medical workers all over the world to directly contact doctors from medical institutions. DingTalk is a digital messaging and communication platform which provides free audio and video conference functionality, along with live broadcast functions for more-complex scenarios.
Through video conferencing and real-time artificial intelligence (AI) translation into 11 languages (Arabic, Bahasa, Chinese, English, French, Japanese, Russian, Spanish, Thai, Turkish, and Vietnamese), Alibaba Cloud aims to build a virtual community, inviting Chinese doctors to share their experiences and answer questions from global peers.
Cette histoire est tirée de l'édition April 2020 de BioSpectrum Asia.
Abonnez-vous à Magzter GOLD pour accéder à des milliers d'histoires premium sélectionnées et à plus de 9 000 magazines et journaux.
Déjà abonné ? Se connecter
PLUS D'HISTOIRES DE BioSpectrum Asia
BioSpectrum Asia
Kyorin and Lunatus partner to launch Lasvic tablets in 9 Middle Eastern countries
Japan's Kyorin Pharmaceutical has entered into an exclusive distribution agreement with Lunatus Marketing & Consulting FZCO for Lasvic tablets (Lascufloxacin hydrochloride).
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Biotium launches GlycoLiner Cell Surface Glycoprotein Labeling Kits
US-based Biotium, a leading innovator in fluorescent dyes and life science reagents, has announced the launch of GlycoLiner Cell Surface Glycoprotein Labeling Kits for rapid, selective, and covalent labeling of cell surface glycoproteins.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vaxxas appoints former Merck Global Vaccines President David Peacock as CEO
Australia-based Vaxxas has announced the appointment of global biopharmaceutical executive David Peacock as Chief Executive Officer (CEO) to lead the commercialisation of the company's proprietary high-density microarray patch (HD-MAP) vaccination technology.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Thermo Fisher partners with NVIDIA leveraging AI to advance scientific instrumentation
US-based Thermo Fisher Scientific Inc. has announced a strategic collaboration with NVIDIA to power artificial intelligence (AI)based solutions and laboratory automation at scale.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bruker consolidates ownership of TOFWERK in expansion of mass spectrometry portfolio
Bruker Corporation has announced the acquisition of an additional 60 per cent ownership stake in TOFWERK AG, a Switzerland-based innovator in ultra-fast time-of-flight (TOF) mass spectrometry technology for small molecule applied markets, consolidating Bruker's ownership to 100 per cent.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Bioengineered tissue by Japan emerges as revolutionary treatment for secondary lymphedema
A research team led by Associate Professor Kosuke Kusamori from the Faculty of Pharmaceutical Sciences at Tokyo University of Science (TUS), Japan, is pioneering an innovative technique for lymphatic tissue engineering that could revolutionize the treatment of secondary lymphedema.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Chitose and Fujifilm Biosciences to drive global innovation and biopharma manufacturing
Japan-based Chitose Laboratory Corp. & Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Vibrant Therapeutics on-boards Dr Han Lee as Co-CEO
Vibrant Therapeutics, a clinical-stage biotechnology company based in China and US, has announced the appointment of Dr Han Lee as co-chief executive officer (CEO).
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
IIT-D and AIIMS develop swallowable microdevice for microbiome study
Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.
1 min
BioSpectrum Asia Feb 2026
BioSpectrum Asia
Ambitious research to develop multivalent vaccines against multiple deadly filoviruses
Scientists at the University of Oxford, in collaboration with partners, will spearhead the development of new vaccines that aim to provide comprehensive protection against multiple lethal filoviruses, including Ebola virus, Sudan virus, Bundibugyo virus, and Marburg virus.
1 min
BioSpectrum Asia Feb 2026
Translate
Change font size
